CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer Steven Engle will present at the Mitochondria-Targeted Drug Development Summit being held virtually on April 27 - 29, 2021.
April 14, 2021
· 5 min read